Hershey's Margin Recovery Begins, but Valuation Leaves Little Room for Error

What happened

A Seeking Alpha article reports that Hershey's Q1 2026 earnings showed a rapid margin rebound, with easing input cost pressures enabling renewed investment for long-term growth after two challenging years of commodity inflation. However, the DeepValue Master Report, based on full-year 2025 data, cautions that the stock at ~$188 (~28x EPS) already prices in a robust post-2025 recovery, trading ~45% above a conservative DCF anchor. While gross margins compressed 650–700 bps in 2025 due to cocoa, sugar, labor, and tariff shocks, the franchise is high-quality but the margin of safety is thin at current levels. The news confirms the recovery narrative, yet structural cost increases—from cocoa volatility, tariffs, and regulatory demands—may keep normalized margins below historical peaks. Thus, the narrative shifts from crisis to recovery, but the valuation leaves little room for error, and investors should weigh the pace of margin normalization against the risk of multiple compression.

Implication

The positive Q1 2026 margin data supports Hershey's pricing power and productivity initiatives, potentially justifying a higher multiple. However, the stock trades at a ~45% premium to a conservative DCF estimate, leaving a thin margin of safety. Structural headwinds—elevated cocoa costs, tariffs, and regulatory requirements—may keep margins below pre-2025 peaks even after the cycle normalizes. For value-oriented investors, the risk/reward remains skewed toward waiting for a better entry price (e.g., a pullback toward the $130s DCF anchor) or clearer evidence that margin recovery is durable and not merely cyclical. If margins continue improving and the stock corrects, the stance could shift to a more constructive BUY.

Thesis delta

The earlier stance of 'WAIT' is now reinforced by evidence of a margin recovery, reducing the risk of prolonged trough earnings. However, the stock's premium to intrinsic value remains high, so the thesis shifts from 'potential BUY on pullback' to 'still WAIT' but with increased confidence in the recovery trajectory. The key uncertainty is whether normalized margins will structurally settle below historical levels, which the current price may not fully discount.